CC(C)CC(=O)CC(C)[C@]1(CCCOCc2ccccc2)C(=O)N2CCC3(C[C@@]24CCC[C@@H]14)OCCO3
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?